The estrogen receptor-α A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study
2005

Low Frequency of ER-α A908G Mutation in Breast Tumors

Sample size: 653 publication Evidence: moderate

Author Information

Author(s): Conway Kathleen, Parrish Eloise, Edmiston Sharon N, Tolbert Dawn, Tse Chiu-Kit, Geradts Joseph, Livasy Chad A, Singh Harsharan, Newman Beth, Millikan Robert C

Primary Institution: University of North Carolina, Chapel Hill, NC, USA

Hypothesis

Does the ER-α A908G mutation occur in invasive breast tumors?

Conclusion

The study confirms the presence of the ER-α A908G mutation in invasive breast tumors, particularly in higher-grade tumors.

Supporting Evidence

  • The ER-α A908G mutation was detected in 37 of 653 (5.7%) breast tumors.
  • The mutation was found more frequently in higher-grade breast tumors.
  • The absence of this mutation in germline DNA confirmed it to be somatic.
  • Mixed lobular/ductal tumors had a higher prevalence of the mutation.

Takeaway

This study looked at breast tumors to see if a specific mutation was present. They found it in a small number of tumors, especially in those that were more aggressive.

Methodology

The study screened 653 invasive breast tumors for the ER-α A908G mutation using SSCP analysis and 33P-cycle sequencing.

Limitations

The study is based on a relatively small number of mutation-positive tumors.

Participant Demographics

Participants included African American and white women aged 20 to 74 years.

Statistical Information

P-Value

0.03

Confidence Interval

95% CI 1.09 to 7.34

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1315

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication